Dr. Schiller is a Yale and University of Chicago trained psychiatrist who has been a leader in the development of technologies that provide an objective and effective basis for guiding psychiatric medical treatment. He received his M.D. from the University of Chicago Pritzker School of Medicine and has an MS in Economics from Golden Gate University. Additionally, he has been honored as a Distinguished Fellow of the American Psychiatric Association (DFAPA).
He continues his research involvement in his role as Director of Medical Affairs of CNS Response, now Mynd Analytics. He is also the developer of Referenced Electroencephalogram (rEEG) which assists psychiatrists with medication selection. In addition to his work on electrophysiological technology, Dr. Schiller also focuses on the medication treatment of a broad range of difficult-to-treat psychiatric disorders. These disorders include treatment-resistant depression, anxiety disorders, schizophrenia, bipolar disorder, eating disorders, adult attention deficit disorder, and addiction. The latter is a focus of his work as a consultant for the Bayside Marin Center drug and alcohol program.